Trial Profile
Effects of Injection Tinzaparin Prophylactic Dose (4,500 IU Anti-Xa) on Thrombin Generation in Patients With Multiple Myeloma, Lymphoma Patients and Patients Hospitalized for an Acute Medical Condition
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Thrombosis; Venous thromboembolism
- Focus Pharmacodynamics
- Acronyms METRO B
- 10 May 2017 Status changed from recruiting to completed.
- 27 Oct 2016 Planned number of patients changed from 24 to 19.
- 14 Jun 2016 Planned End Date changed from 1 Nov 2017 to 1 Jul 2017.